1 Min Read
NEW YORK, Sept 21 (Reuters) - ViroPharma Inc : * Jumps 6.5 percent to $30 in premarket after FDA lifts hold on Cinryze testing
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.